The Clinical Trials Unit at Kennedy Krieger focuses on studies of many disorders in the medical and mental health field.

Currently Recruiting Trials

The following studies are currently accepting new participants:

Children Ages 7-17 Years Affected by Depression and Experiencing Symptoms

Research Study Seeking Participants with Psychosis, ADHD + Aggression, ADHD, Depression, Bipolar Disorder, and Anxiety

Children Ages 10-17 Years with Bipolar Disorder

Adolescents Diagnosed with Schizophrenia, Ages 12-16 Years

Allergan Anxiety- Adolescents Ages 7-17 years and Diagnosed with General Anxiety

FORWARD- Fragile X Registry Study

Acadia Rett-Children and Adolescents, Female, Ages 5-20 years old with a Diagnosis of Rett Syndrome

LAP01- Adolescent Registry Antipsychotics Ages 3-17 years on Abilify or Risperidone

LuMind- Adults Ages 25 years or older with Down Syndrome Lundbeck 9A- Adolescents Ages 6-17 years with Major Depressive Disorder

Zynerba- Children and Adolescents Age 3-17 years with Fragile X

Supernus 810P503- Adolescents Ages 12-17 years with ADHD and Impulsive Aggression

Many studies for a range of diagnoses and disorders will be approved in the near future. To ensure you are among the first to learn of new studies when they open, please contact us by email or phone.

Request to Participate in Clinical Trials

Contact Us

716 North Broadway
Baltimore, MD 21205
Phone: (443)923-3850
Email: ResearchTrials@KennedyKrieger.org